You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC / CE

Practical Discharge Strategies to Prevent SCD: Test Your Skills

  • Authors: Deepak L. Bhatt, MD, MPH; Barry H. Greenberg, MD
  • CME / ABIM MOC / CE Released: 6/20/2016
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 6/20/2017, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, primary care physicians, critical care specialists, emergency medicine physicians, nurses, and all clinicians interested in preventing SCD in at-risk patients.

The goal of this activity is to improve the remote management of patients at high risk for sudden cardiac arrest (SCA)/sudden cardiac death (SCD) by educating clinicians about SCA/SCD guidelines, risk assessment tools, and prevention measures.

Upon completion of this activity, participants will be able to:

  1. Assess appropriate patients for risk of SCA/SCD at hospital discharge
  2. Implement effective strategies in the hospital and at discharge to prevent SCA/SCD in patients at risk


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Deepak L. Bhatt, MD, MPH

    Professor of Medicine, Harvard Medical School; Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center, Boston, Massachusetts

    Disclosures

    Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
    Received grants for clinical research from: Amarin Corporation plc; AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Inc.; Ethicon, Inc.; Forest Laboratories, Inc.; Ischemix, Inc.; Medtronic, Inc.; Pfizer Inc; Roche; Sanofi; The Medicines Company

    Dr Bhatt does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Bhatt does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Barry H. Greenberg, MD

    Professor of Medicine; Director, Advanced Heart Failure Treatment Program, University of California, San Diego, La Jolla, California

    Disclosures

    Disclosure: Barry H. Greenberg, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Celladon; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Mast Therapeutics, Inc.; Novartis Pharmaceuticals Corporation; Stealth Peptides Inc.; Teva Pharmaceuticals USA; Zensun USA Inc.
    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; Relypsa, Inc.

    Dr Greenberg does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Greenberg does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editors

  • Joy P. Marko, MS, APN-C, CCMEP

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Joy P. Marko, MS, APN-C, CCMEP, has disclosed no relevant financial relationships.

  • Kalanathee Paul-Pletzer, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Kalanathee Paul-Pletzer, PhD, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

    Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Practical Discharge Strategies to Prevent SCD: Test Your Skills

Authors: Deepak L. Bhatt, MD, MPH; Barry H. Greenberg, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 6/20/2016

Valid for credit through: 6/20/2017, 11:59 PM EST

processing....

The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.

Case 1: Presentation

MT, a 68-year-old white man, was brought to the emergency department by his wife after he experienced chest discomfort that did not resolve after 6 to 7 hours. He initially thought that his symptoms were due to indigestion and heartburn and was thus reluctant to seek medical help. His medical history is significant for hyperlipidemia (treated with atorvastatin 10 mg/d), mild hypertension (controlled on a salt-restricted diet without medical therapy), and type 2 diabetes mellitus (diet controlled without medical therapy).

An electrocardiogram, obtained within 10 minutes of arrival at the emergency department, showed ST elevation of 3 to 4 mm anteriorly. On coronary angiography, performed within 58 minutes of presentation, a completely occluded proximal left anterior descending (LAD) artery and 40%, 50%, and 50% stenoses of the proximal, middle, and distal portions of the right coronary artery (RCA), respectively, were noted. A left ventriculogram revealed akinesia of the anterior wall, anterior septum, and left ventricular (LV) apex, with an estimated LV ejection fraction (LVEF) of 25%.

MT underwent primary percutaneous coronary intervention (PCI) with implantation of a second-generation drug-eluting stent, which successfully restored patency of the LAD artery. On day 2 after PCI, he seemed to be doing relatively well, with no overt ischemic symptoms on ambulation. Occasional premature ventricular contractions (PVCs) were noted on telemetry, without evidence of sustained ventricular tachycardia (VT). His LVEF was 30% as determined by echocardiography.

  • Print